Right Team
Our team brings together over 150 years of combined experience in drug discovery and development. With a proven track record of delivering best-in-class medicines, we combine deep disease biology expertise with cutting-edge technologies. The team has successfully advanced both small and large molecule programmes across immunology and oncology.
-
Pierre Raboisson
Chief Executive Officer
-
Marie De Vulder
Chief Legal Officer
-
Francois Gonzalvez
Chief Scientific Officer
-
Pieter Peeters
Chief Technology & Operations Officer
-
Sandrine Vendeville
VP, Head of Chemistry
-
Joost Kolkman
VP, Head of Biologics
-
John-Paul Gallivan
SVP, Head of Development
-
Fabrice Kolb
VP, Head of Immunology